| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910137117303321 |
|
|
Autore |
Shiotani Akiko |
|
|
Titolo |
Management of Helicobacter pylori-related diseases / / Akiko Shiotani, David Y. Graham |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Philadelphia, Pennsylvania : , : Elsevier, , 2015 |
|
©2015 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (246 p.) |
|
|
|
|
|
|
Collana |
|
Gastroenterology Clinics of North America, , 0889-8553 ; ; Volume 44, Number 3 |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
"Clinics Review Articles." |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references at the end of each chapters and index. |
|
|
|
|
|
|
|
|
Nota di contenuto |
|
Cover image; Title page; Table of Contents; Copyright Page; Contributors; Consulting Editor; Editors; Authors; Forthcoming Issues; Forthcoming Issues; Recent Issues; Foreword: Helicobacter pylori; Preface: Helicobacter pylori: New Thoughts and Practices; Diagnosis of Helicobacter pylori Infection in the Proton Pump Inhibitor Era; Key points; Introduction; Invasive tests; Serology; Summary: diagnosis of Helicobacter pylori infection in the proton pump inhibitors era; Practical Aspects in Choosing a Helicobacter pylori Therapy; Key points; Introduction; Choice of therapy; First-line regimens |
Rescue therapyProbiotics; Summary; How to Effectively Use Bismuth Quadruple Therapy; Key points; Background; Bismuth in the era of new concepts regarding pathogenesis and treatment of peptic ulcer; Bismuth quadruple therapy for H pylori eradication; The effect of metronidazole resistance as examined by meta-analysis; Calculation of the effectiveness of bismuth quadruple therapy; Adherence (compliance) with bismuth quadruple therapy; How to make bismuth quadruple therapy more acceptable; Doxycycline |
Examination of outcome in regions where bismuth quadruple therapy frequently fails (eg, Turkey and Iran)Bismuth, tetracycline, amoxicillin, proton pump inhibitors quadruple therapy; Bismuth sequential therapies; Information needed to obtain generalizable results; Issues |
|
|
|
|
|
|
|
|
|
|
ripe for systematic study; Proton pump inhibitors dosage; Efficient study design; Recommendations; Is There a Role for Probiotics in Helicobacter pylori Therapy?; Key points; What probiotics are; Probiotics; Probiotics as adjuvant therapy for Helicobacter pylori eradication; Probiotics as cure for Helicobacter pylori infection |
SummaryMolecular Approaches to Identify Helicobacter pylori Antimicrobial Resistance; Key points; Molecular determination of Helicobacter pylori resistance to macrolides; Molecular determination of Helicobacter pylori resistance to fluoroquinolones; Molecular determination of Helicobacter pylori resistance to tetracycline; Molecular determination of Helicobacter pylori resistance to other antibiotics; When Is Endoscopic Follow-up Appropriate After Helicobacter pylori Eradication Therapy?; Key points; Introduction; Helicobacter pylori eradication; Uninvestigated and nonulcer dyspepsia |
Peptic ulcerPremalignant gastric lesions and early gastric cancer; Hereditary risk for gastric cancer; Mucosa-associated lymphoid tissue lymphoma; Summary; Gastric Cancer Risk in Patients with Helicobacter pylori Infection and Following Its Eradication; Key points; Introduction; Helicobacter pylori infection is the most important determinant of gastric cancer risk; Gastric cancer risk: epidemiologic trends; Gastric cancer risk: the assessment; Gastric cancer risk in eradicated patients; Summary; Molecular Pathogenesis of Helicobacter pylori-Related Gastric Cancer; Key points; Introduction |
Classifications and characterizations of gastric cancer |
|
|
|
|
|
| |